Trials / Completed
CompletedNCT03802526
Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2
Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- NVP Healthcare · Industry
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics and safety/tolerability between NVP-1805-R1 and NVP-1805-R2
Detailed description
pharmacokinetics and safety/tolerability between NVP-1805-R1 and NVP-1805-R2
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NVP-1805-R1 | 1 tablet, multiple oral dosing |
| DRUG | NVP-1805-R2 | 1 tablet, multiple oral dosing |
| DRUG | NVP-1805-R1 and NVP-1805-R2 | NVP-1805-R1,1 tablet and NVP-1805-R2, 1 tablet, co-administration, multiple oral dosing |
Timeline
- Start date
- 2019-04-03
- Primary completion
- 2019-07-04
- Completion
- 2019-09-27
- First posted
- 2019-01-14
- Last updated
- 2019-11-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03802526. Inclusion in this directory is not an endorsement.